Insights

Precision Diagnostics Leverage Invivoscribe’s expanding IVDR portfolio and certified IgH and FLT3 assays to target European and UK markets seeking validated companion diagnostics and high-specificity hematologic cancer tests.

MRD & NGS Growth Promote the LeukoStrat KMT2A + MRD assay and collaboration with NGS platforms to oncology trials and precision medicine programs, addressing high-sensitivity leukemia testing needs in research and clinical settings.

Automated Workflows Highlight the new automated nucleic acid extraction and quantification system to laboratories aiming to standardize pre-analytical steps, reduce variability, and boost throughput across molecular testing workflows.

Global Lab Network Position LabPMM and Invivoscribe’s global testing capabilities as a turnkey solution for pharmaceutical and biotech partners requiring standardized, multi-region diagnostic support for hematologic cancers.

Platform Expansion Explore collaborations around PrepQuant kits and broadening platform capabilities to cover full molecular testing workflows, aligning with CROs, biopharma, and contract diagnostics partners seeking integrated assay ecosystems.

Similar companies to Invivoscribe

Invivoscribe Tech Stack

Invivoscribe uses 8 technology products and services including Microsoft Clarity, Amazon Web Services, Sketch, and more. Explore Invivoscribe's tech stack below.

Media & News

Invivoscribe's Email Address Formats

Invivoscribe uses at least 3 email formats:
Invivoscribe Email FormatsExamplePercentage
FLast@invivoscribe.comJDoe@invivoscribe.com
92%
First.Last@invivoscribe.comJohn.Doe@invivoscribe.com
7%
Last@invivoscribe.comDoe@invivoscribe.com
1%

Frequently Asked Questions

What is Invivoscribe's phone number?

Minus sign iconPlus sign icon
You can contact Invivoscribe's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Invivoscribe's official website and social media links?

Minus sign iconPlus sign icon
Invivoscribe's official website is invivoscribe.com and has social profiles on LinkedIn.

How much revenue does Invivoscribe generate?

Minus sign iconPlus sign icon
As of October 2026, Invivoscribe's annual revenue is estimated to be $50M - $100M.

What is Invivoscribe's SIC code and NAICS code?

Minus sign iconPlus sign icon
Invivoscribe's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Invivoscribe have currently?

Minus sign iconPlus sign icon
As of October 2026, Invivoscribe has approximately 207 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: D. C., Chief Commercial Officer: A. D. A. and Chief Financial Officer: M. B. Explore Invivoscribe's employee directory with LeadIQ.

What industry does Invivoscribe belong to?

Minus sign iconPlus sign icon
Invivoscribe operates in the Biotechnology Research industry.

What technology does Invivoscribe use?

Minus sign iconPlus sign icon
Invivoscribe's tech stack includes Microsoft Clarity, Amazon Web Services, Sketch, Bluebeam, WooCommerce, Microsoft Intune, Marketo and Stripe.

What is Invivoscribe's email format?

Minus sign iconPlus sign icon
Invivoscribe's email format typically follows the pattern of FLast@invivoscribe.com. Find more Invivoscribe email formats with LeadIQ.

When was Invivoscribe founded?

Minus sign iconPlus sign icon
Invivoscribe was founded in 1995.
Invivoscribe logo

Invivoscribe

Biotechnology ResearchCalifornia, United States201-500 Employees

Invivoscribe is a biotechnology research company based at 10222 Barnes Canyon Road Building 1, San Diego, California, United States, with 51-200 employees. The company is described as a global leader in precision diagnostics, providing oncology-focused products and clinical services to improve healthcare quality. It manufactures products in a state-of-the-art cGMP facility and offers a broad range of platform-agnostic assays, reagents, controls, and software for clonal gene rearrangements, translocations, gene mutations, and measurable residual disease testing. Its subsidiary, LabPMM (Laboratory for Personalized Molecular Medicine), delivers clinical diagnostic and biopharma services for detection and monitoring of myelo- and lymphoproliferative disorders, operating a globally standardized network for flow cytometry and molecular testing across the U.S., Europe, and Asia. Invivoscribe's work centers on accelerating therapeutic development through a streamlined CDx companion diagnostic model and supporting patient care with precision oncology tools.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1995
Employees
201-500

Section iconFunding & Financials

  • $50M - $100M

    Invivoscribe's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.